Jan. 30, 2025 — The antibody targets a stable part of the bird flu virus, ensuring that the immune ... the first season following the approval of RSV vaccines. The vaccine effectively prevented ...

In this week's edition of Local Motion, KVNF's weekly public affairs program, we talk to Leah Rawson and Shirley Tatto of ...

The human respiratory syncytial virus (HRSV) is one of the main agents of bronchiolitis ... since the two viruses have similar virion structure and genome organisation (5, 6). Like HCV, BVDV utilizes ...

Learn to recognize dangerous RSV symptoms in children beyond typical cold signs, including breathing changes, distinctive ...

Insect miRNAs can be transferred to their host plants upon feeding. This study shows that a conserved insect microRNA plays a ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older.

RSV is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections and pneumonia. In the UK, RSV has an impact on elderly adults and is responsible for ...

For over a century, scientists have analyzed the vast microbial world within the human body. They’ve found bacteria, fungi, ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

SARS-CoV-2 secondary structure shapes mutation frequencies, constraining viral evolution models predicting fitness can benefit from integrating secondary structure data.